Engelund; Dorthe Kot

Patent Applications and Registrations

Patent applications and USPTO patent grants for Engelund; Dorthe Kot.The latest application filed is for "stable semaglutide compositions and uses thereof".

Company Profile

2.11.22

Engelund; Dorthe Kot - Holte DK

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
GLP-1 compositions and uses thereof Grant 11,318,191 - Engelund , et al. May 3, 2	2022-05-03
Stable Semaglutide Compositions And Uses Thereof App 20210379159 - Engelund; Dorthe Kot ; et al.	2021-12-09
Glp-1 Compositions And Uses Thereof App 20210252111 - Engelund; Dorthe Kot ; et al.	2021-08-19
Stable multi-dose compositions comprising an antibody and a preservative Grant 10,835,602 - Parshad , et al. November 17, 2	2020-11-17
Propylene Glycol-containing Peptide Formulations Which Are Optimal For Production And For Use In Injection Devices App 20200316204 - Pedersen; Tina Bjeldskov ; et al.	2020-10-08
Propylene Glycol-Containing Peptide Formulations which are Optimal for Production and for Use in Injection Devices App 20190231876 - Pedersen; Tina Bjeldskov ; et al.	2019-08-01
Stable Multi-Dose Compositions Comprising an Antibody and a Preservative App 20180104335 - Parshad; Henrik ; et al.	2018-04-19
Stable Antibody Containing Compositions App 20180000935 - Parshad; Henrik ; et al.	2018-01-04
Stable antibody containing compositions Grant 9,795,674 - Parshad , et al. October 24, 2	2017-10-24
Stable formulation of modified GLP-1 Grant 8,846,618 - Flink , et al. September 30, 2	2014-09-30
Stable formulations of peptides Grant 8,748,376 - Ludvigsen , et al. June 10, 2	2014-06-10
Stable Multi-Dose Compositions Comprising an Antibody and a Preservative App 20130136733 - Parshad; Henrik ; et al.	2013-05-30
Stable Antibody Containing Compositions App 20130028907 - Parshad; Henrik ; et al.	2013-01-31
Propylene Glycol-containing Peptide Formulations Which Are Optimal For Production And For Use In Injection Devices App 20120225810 - Pedersen; Tina Bjeldskov ; et al.	2012-09-06
Soluble pharmaceutical compositions for parenteral administration comprising a GLP-1 peptide and an insulin peptide of short time action for treatment of diabetes and bulimia Grant 8,158,583 - Knudsen , et al. April 17, 2	2012-04-17
Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices Grant 8,114,833 - Pedersen , et al. February 14, 2	2012-02-14
Stable Formulation Of Modified Glp-1 App 20100234299 - FLINK; JAMES M. ; et al.	2010-09-16
Stable Formulations of Peptides App 20100173844 - Ludvigsen; Svend ; et al.	2010-07-08
Soluble Pharmaceutical Compositions for Parenteral Administration Comprising a GLP-1 Peptide and an Insulin Peptide of Short Time Action for Treatment of Diabetes and Bulimia App 20090286716 - Knudsen; Liselotte Bjerre ; et al.	2009-11-19
Stable pharmaceutical compositions Grant 7,595,293 - Engelund , et al. September 29, 2	2009-09-29
Stable Formulation of Modified GLP-1 App 20090111752 - Flink; James M. ; et al.	2009-04-30
Stable formulation of modified GLP-1 App 20080167226 - Flink; James M. ; et al.	2008-07-10
Stable Formulations Of Peptides App 20080125361 - Ludvigsen; Svend ; et al.	2008-05-29
Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices App 20070010424 - Pedersen; Tina Bjeldskov ; et al.	2007-01-11
Soluble pharmaceutical compositions for parenteral administration comprising a GLP-1 peptide and an insulin peptide of short time action for treatment of diabetes and bulimia App 20060287221 - Knudsen; Liselotte Bjerre ; et al.	2006-12-21
Stable pharmaceutical compositions App 20060084605 - Engelund; Dorthe Kot ; et al.	2006-04-20
GLP-2 compounds, formulations, and uses thereof App 20040122210 - Thim, Lars ; et al.	2004-06-24
Stable formulation of modified GLP-1 App 20030119734 - Flink, James M. ; et al.	2003-06-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.